Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Metastatic Malignant Melanoma Therapy Revenue 1.4 Market Analysis by Type 1.4.1 Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Immunotherapy 1.4.3 Targeted Therapy 1.4.4 Other 1.5 Market by Application 1.5.1 Global Metastatic Malignant Melanoma Therapy Market Share by Application: 2020 VS 2026 1.5.2 Hospital 1.5.3 Medical Research Organization 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Metastatic Malignant Melanoma Therapy Market Perspective (2015-2026) 2.2 Metastatic Malignant Melanoma Therapy Growth Trends by Regions 2.2.1 Metastatic Malignant Melanoma Therapy Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Metastatic Malignant Melanoma Therapy Historic Market Share by Regions (2015-2020) 2.2.3 Metastatic Malignant Melanoma Therapy Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Metastatic Malignant Melanoma Therapy Market Growth Strategy 2.3.6 Primary Interviews with Key Metastatic Malignant Melanoma Therapy Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Metastatic Malignant Melanoma Therapy Players by Market Size 3.1.1 Global Top Metastatic Malignant Melanoma Therapy Players by Revenue (2015-2020) 3.1.2 Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Players (2015-2020) 3.1.3 Global Metastatic Malignant Melanoma Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Metastatic Malignant Melanoma Therapy Market Concentration Ratio 3.2.1 Global Metastatic Malignant Melanoma Therapy Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Metastatic Malignant Melanoma Therapy Revenue in 2019 3.3 Metastatic Malignant Melanoma Therapy Key Players Head office and Area Served 3.4 Key Players Metastatic Malignant Melanoma Therapy Product Solution and Service 3.5 Date of Enter into Metastatic Malignant Melanoma Therapy Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Metastatic Malignant Melanoma Therapy Historic Market Size by Type (2015-2020) 4.2 Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Type (2021-2026) 5 Metastatic Malignant Melanoma Therapy Breakdown Data by Application (2015-2026) 5.1 Global Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) 5.2 Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Metastatic Malignant Melanoma Therapy Market Size (2015-2020) 6.2 Metastatic Malignant Melanoma Therapy Key Players in North America (2019-2020) 6.3 North America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) 6.4 North America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) 7 Europe 7.1 Europe Metastatic Malignant Melanoma Therapy Market Size (2015-2020) 7.2 Metastatic Malignant Melanoma Therapy Key Players in Europe (2019-2020) 7.3 Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) 7.4 Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) 8 China 8.1 China Metastatic Malignant Melanoma Therapy Market Size (2015-2020) 8.2 Metastatic Malignant Melanoma Therapy Key Players in China (2019-2020) 8.3 China Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) 8.4 China Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) 9 Japan 9.1 Japan Metastatic Malignant Melanoma Therapy Market Size (2015-2020) 9.2 Metastatic Malignant Melanoma Therapy Key Players in Japan (2019-2020) 9.3 Japan Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) 9.4 Japan Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Metastatic Malignant Melanoma Therapy Market Size (2015-2020) 10.2 Metastatic Malignant Melanoma Therapy Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) 10.4 Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) 11 India 11.1 India Metastatic Malignant Melanoma Therapy Market Size (2015-2020) 11.2 Metastatic Malignant Melanoma Therapy Key Players in India (2019-2020) 11.3 India Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) 11.4 India Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Metastatic Malignant Melanoma Therapy Market Size (2015-2020) 12.2 Metastatic Malignant Melanoma Therapy Key Players in Central & South America (2019-2020) 12.3 Central & South America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) 12.4 Central & South America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) 13Key Players Profiles 13.1 Merck 13.1.1 Merck Company Details 13.1.2 Merck Business Overview and Its Total Revenue 13.1.3 Merck Metastatic Malignant Melanoma Therapy Introduction 13.1.4 Merck Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020)) 13.1.5 Merck Recent Development 13.2 Pfizer 13.2.1 Pfizer Company Details 13.2.2 Pfizer Business Overview and Its Total Revenue 13.2.3 Pfizer Metastatic Malignant Melanoma Therapy Introduction 13.2.4 Pfizer Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) 13.2.5 Pfizer Recent Development 13.3 Janssen Biotech 13.3.1 Janssen Biotech Company Details 13.3.2 Janssen Biotech Business Overview and Its Total Revenue 13.3.3 Janssen Biotech Metastatic Malignant Melanoma Therapy Introduction 13.3.4 Janssen Biotech Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) 13.3.5 Janssen Biotech Recent Development 13.4 Roche 13.4.1 Roche Company Details 13.4.2 Roche Business Overview and Its Total Revenue 13.4.3 Roche Metastatic Malignant Melanoma Therapy Introduction 13.4.4 Roche Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) 13.4.5 Roche Recent Development 13.5 Navidea 13.5.1 Navidea Company Details 13.5.2 Navidea Business Overview and Its Total Revenue 13.5.3 Navidea Metastatic Malignant Melanoma Therapy Introduction 13.5.4 Navidea Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) 13.5.5 Navidea Recent Development 13.6 Novartis 13.6.1 Novartis Company Details 13.6.2 Novartis Business Overview and Its Total Revenue 13.6.3 Novartis Metastatic Malignant Melanoma Therapy Introduction 13.6.4 Novartis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) 13.6.5 Novartis Recent Development 13.7 Bristol-Myers Squibb 13.7.1 Bristol-Myers Squibb Company Details 13.7.2 Bristol-Myers Squibb Business Overview and Its Total Revenue 13.7.3 Bristol-Myers Squibb Metastatic Malignant Melanoma Therapy Introduction 13.7.4 Bristol-Myers Squibb Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) 13.7.5 Bristol-Myers Squibb Recent Development 13.8 Enzon Pharmaceuticals 13.8.1 Enzon Pharmaceuticals Company Details 13.8.2 Enzon Pharmaceuticals Business Overview and Its Total Revenue 13.8.3 Enzon Pharmaceuticals Metastatic Malignant Melanoma Therapy Introduction 13.8.4 Enzon Pharmaceuticals Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) 13.8.5 Enzon Pharmaceuticals Recent Development 13.9 Exelixis 13.9.1 Exelixis Company Details 13.9.2 Exelixis Business Overview and Its Total Revenue 13.9.3 Exelixis Metastatic Malignant Melanoma Therapy Introduction 13.9.4 Exelixis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) 13.9.5 Exelixis Recent Development 13.10 GlaxoSmithKline 13.10.1 GlaxoSmithKline Company Details 13.10.2 GlaxoSmithKline Business Overview and Its Total Revenue 13.10.3 GlaxoSmithKline Metastatic Malignant Melanoma Therapy Introduction 13.10.4 GlaxoSmithKline Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) 13.10.5 GlaxoSmithKline Recent Development 13.11 Ono Pharmaceutical 10.11.1 Ono Pharmaceutical Company Details 10.11.2 Ono Pharmaceutical Business Overview and Its Total Revenue 10.11.3 Ono Pharmaceutical Metastatic Malignant Melanoma Therapy Introduction 10.11.4 Ono Pharmaceutical Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) 10.11.5 Ono Pharmaceutical Recent Development 13.12 Amgen 10.12.1 Amgen Company Details 10.12.2 Amgen Business Overview and Its Total Revenue 10.12.3 Amgen Metastatic Malignant Melanoma Therapy Introduction 10.12.4 Amgen Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) 10.12.5 Amgen Recent Development 14Analyst's Viewpoints/Conclusions 15Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Metastatic Malignant Melanoma Therapy Key Market Segments Table 2. Key Players Covered: Ranking by Metastatic Malignant Melanoma Therapy Revenue Table 3. Ranking of Global Top Metastatic Malignant Melanoma Therapy Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Metastatic Malignant Melanoma Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Immunotherapy Table 6. Key Players of Targeted Therapy Table 7. Key Players of Other Table 8. Global Metastatic Malignant Melanoma Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 9. Global Metastatic Malignant Melanoma Therapy Market Size by Regions (US$ Million): 2020 VS 2026 Table 10. Global Metastatic Malignant Melanoma Therapy Market Size by Regions (2015-2020) (US$ Million) Table 11. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2015-2020) Table 12. Global Metastatic Malignant Melanoma Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 13. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2021-2026) Table 14. Market Top Trends Table 15. Key Drivers: Impact Analysis Table 16. Key Challenges Table 17. Metastatic Malignant Melanoma Therapy Market Growth Strategy Table 18. Main Points Interviewed from Key Metastatic Malignant Melanoma Therapy Players Table 19. Global Metastatic Malignant Melanoma Therapy Revenue by Players (2015-2020) (Million US$) Table 20. Global Metastatic Malignant Melanoma Therapy Market Share by Players (2015-2020) Table 21. Global Top Metastatic Malignant Melanoma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Malignant Melanoma Therapy as of 2019) Table 22. Global Metastatic Malignant Melanoma Therapy by Players Market Concentration Ratio (CR5 and HHI) Table 23. Key Players Headquarters and Area Served Table 24. Key Players Metastatic Malignant Melanoma Therapy Product Solution and Service Table 25. Date of Enter into Metastatic Malignant Melanoma Therapy Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$) Table 28. Global Metastatic Malignant Melanoma Therapy Market Size Share by Type (2015-2020) Table 29. Global Metastatic Malignant Melanoma Therapy Revenue Market Share by Type (2021-2026) Table 30. Global Metastatic Malignant Melanoma Therapy Market Size Share by Application (2015-2020) Table 31. Global Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$) Table 32. Global Metastatic Malignant Melanoma Therapy Market Size Share by Application (2021-2026) Table 33. North America Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$) Table 34. North America Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020) Table 35. North America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$) Table 36. North America Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020) Table 37. North America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$) Table 38. North America Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020) Table 39. Europe Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$) Table 40. Europe Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020) Table 41. Europe Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$) Table 42. Europe Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020) Table 43. Europe Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$) Table 44. Europe Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020) Table 45. China Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$) Table 46. China Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020) Table 47. China Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$) Table 48. China Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020) Table 49. China Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$) Table 50. China Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020) Table 51. Japan Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$) Table 52. Japan Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020) Table 53. Japan Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$) Table 54. Japan Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020) Table 55. Japan Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$) Table 56. Japan Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020) Table 57. Southeast Asia Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$) Table 58. Southeast Asia Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020) Table 59. Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$) Table 60. Southeast Asia Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020) Table 61. Southeast Asia Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$) Table 62. Southeast Asia Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020) Table 63. India Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$) Table 64. India Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020) Table 65. India Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$) Table 66. India Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020) Table 67. India Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$) Table 68. India Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020) Table 69. Central & South America Key Players Metastatic Malignant Melanoma Therapy Revenue (2019-2020) (Million US$) Table 70. Central & South America Key Players Metastatic Malignant Melanoma Therapy Market Share (2019-2020) Table 71. Central & South America Metastatic Malignant Melanoma Therapy Market Size by Type (2015-2020) (Million US$) Table 72. Central & South America Metastatic Malignant Melanoma Therapy Market Share by Type (2015-2020) Table 73. Central & South America Metastatic Malignant Melanoma Therapy Market Size by Application (2015-2020) (Million US$) Table 74. Central & South America Metastatic Malignant Melanoma Therapy Market Share by Application (2015-2020) Table 75. Merck Company Details Table 76. Merck Business Overview Table 77. Merck Product Table 78. Merck Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 79. Merck Recent Development Table 80. Pfizer Company Details Table 81. Pfizer Business Overview Table 82. Pfizer Product Table 83. Pfizer Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 84. Pfizer Recent Development Table 85. Janssen Biotech Company Details Table 86. Janssen Biotech Business Overview Table 87. Janssen Biotech Product Table 88. Janssen Biotech Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 89. Janssen Biotech Recent Development Table 90. Roche Company Details Table 91. Roche Business Overview Table 92. Roche Product Table 93. Roche Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 94. Roche Recent Development Table 95. Navidea Company Details Table 96. Navidea Business Overview Table 97. Navidea Product Table 98. Navidea Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 99. Navidea Recent Development Table 100. Novartis Company Details Table 101. Novartis Business Overview Table 102. Novartis Product Table 103. Novartis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 104. Novartis Recent Development Table 105. Bristol-Myers Squibb Company Details Table 106. Bristol-Myers Squibb Business Overview Table 107. Bristol-Myers Squibb Product Table 108. Bristol-Myers Squibb Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 109. Bristol-Myers Squibb Recent Development Table 110. Enzon Pharmaceuticals Business Overview Table 111. Enzon Pharmaceuticals Product Table 112. Enzon Pharmaceuticals Company Details Table 113. Enzon Pharmaceuticals Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 114. Enzon Pharmaceuticals Recent Development Table 115. Exelixis Company Details Table 116. Exelixis Business Overview Table 117. Exelixis Product Table 118. Exelixis Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 119. Exelixis Recent Development Table 120. GlaxoSmithKline Company Details Table 121. GlaxoSmithKline Business Overview Table 122. GlaxoSmithKline Product Table 123. GlaxoSmithKline Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 124. GlaxoSmithKline Recent Development Table 125. Ono Pharmaceutical Company Details Table 126. Ono Pharmaceutical Business Overview Table 127. Ono Pharmaceutical Product Table 128. Ono Pharmaceutical Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 129. Ono Pharmaceutical Recent Development Table 130. Amgen Company Details Table 131. Amgen Business Overview Table 132. Amgen Product Table 133. Amgen Revenue in Metastatic Malignant Melanoma Therapy Business (2015-2020) (Million US$) Table 134. Amgen Recent Development Table 135. Research Programs/Design for This Report Table 136. Key Data Information from Secondary Sources Table 137. Key Data Information from Primary Sources List of Figures Figure 1. Global Metastatic Malignant Melanoma Therapy Market Share by Type: 2020 VS 2026 Figure 2. Immunotherapy Features Figure 3. Targeted Therapy Features Figure 4. Other Features Figure 5. Global Metastatic Malignant Melanoma Therapy Market Share by Application: 2020 VS 2026 Figure 6. Hospital Case Studies Figure 7. Medical Research Organization Case Studies Figure 8. Other Case Studies Figure 9. Metastatic Malignant Melanoma Therapy Report Years Considered Figure 10. Global Metastatic Malignant Melanoma Therapy Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Metastatic Malignant Melanoma Therapy Market Share by Regions: 2020 VS 2026 Figure 12. Global Metastatic Malignant Melanoma Therapy Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Metastatic Malignant Melanoma Therapy Market Share by Players in 2019 Figure 15. Global Top Metastatic Malignant Melanoma Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Malignant Melanoma Therapy as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Metastatic Malignant Melanoma Therapy Revenue in 2019 Figure 17. North America Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 19. China Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Japan Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Southeast Asia Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 22. India Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Central & South America Metastatic Malignant Melanoma Therapy Market Size YoY Growth (2015-2020) (Million US$) Figure 24. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Merck Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 26. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Pfizer Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 28. Janssen Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. Janssen Biotech Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 30. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Roche Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 32. Navidea Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Navidea Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 34. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Novartis Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 36. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Bristol-Myers Squibb Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 38. Enzon Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Enzon Pharmaceuticals Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 40. Exelixis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Exelixis Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 42. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. GlaxoSmithKline Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 44. Ono Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. Ono Pharmaceutical Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 46. Amgen Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Amgen Revenue Growth Rate in Metastatic Malignant Melanoma Therapy Business (2015-2020) Figure 48. Bottom-up and Top-down Approaches for This Report Figure 49. Data Triangulation Figure 50. Key Executives Interviewed

Merck Pfizer Janssen Biotech Roche Navidea Novartis Bristol-Myers Squibb Enzon Pharmaceuticals Exelixis GlaxoSmithKline Ono Pharmaceutical Amgen